Form 4: Lemaitre Vascular Director Acquires Shares Through Dividend Equivalent Rights

Director Martha Shadan acquired 1,725 shares of Lemaitre Vascular common stock through the release of dividend equivalent rights.

Summary

• Martha Shadan, a director at Lemaitre Vascular, acquired 1,725 shares of common stock on December 9, 2024.
• The shares were acquired through the release of dividend equivalent rights, which were attached to a restricted stock unit award granted on December 8, 2023.
• These dividend equivalent rights were released on a one-for-one basis, meaning one right was equivalent to one share of common stock.
• The transaction did not involve any monetary payment, as the price per share was $0.

Sentiment

Score: 7

Explanation: The transaction is a routine insider acquisition of shares through dividend equivalent rights, which is generally viewed positively as it aligns management interests with shareholders. There is no negative information in the document.

Positives

• The acquisition of shares by a director can be seen as a positive sign of confidence in the company's future.

Industry Context

This is a standard SEC Form 4 filing, which is common for company insiders when they acquire or dispose of company stock. It provides transparency into insider transactions.

Comparison to Industry Standards

• This type of transaction is common among publicly traded companies as part of executive compensation packages.
• Many companies use restricted stock units and dividend equivalent rights to align the interests of management with those of shareholders.
• The reporting of these transactions is a standard practice to ensure transparency and prevent insider trading.

Stakeholder Impact

• The acquisition of shares by a director can be seen as a positive signal to shareholders.

Key Dates

Keywords

Lemaitre Vascular, Director, Share Acquisition, Dividend Equivalent Rights, Restricted Stock Unit, LMAT, Insider Trading